Catalyst Capital Advisors’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-675,000	Closed	-$3.4M	–	507
2014 Q3	$3.4M	Buy	+675,000	New	+$3.4M	0.44%	72
2014 Q1	–	Sell	-204,000	Closed	-$1.65M	–	326
2013 Q4	$1.65M	Buy	+204,000	New	+$1.65M	0.53%	74